Method of using IL-11 for treating gingivitis
AssigneeGenetics Institute, Inc.
InventorsJames Keith, Paul Schendel
Life of this patent
Estimating the term…
Abstract
Provided by the present invention are methods of treating a variety of disorders including AIDS, arthritis (rheumatoid arthritis, osteoarthritis, spondyloarthropathies), antibiotic induced diarrheal diseases (Clostridium difficile), multiple sclerosis, osteoporosis, gingivitis, peptic ulcer disease, esophagitis, diabetes, retinitis, uveitis, reperfusion injury after myocardial infarction (MI) or cerebral vascular accident (CVA), aphthous ulcers (oral), atherosclerosis (plaque rupture), prevention of tumor metastases, asthma, preeclampsia, and allergic disorders such as rhinitis, conjunctivitis, and urticaria.
Claims20
A method of treating gingivitis in a patient, comprising administering to a patient in need thereof a pharmaceutically effective amount of IL-11.
Dependencies are inferred from the claim text.